[PDF][PDF] Differential expression and immune correlation analysis of COVID-19 receptor ACE2 and TMPRSS2 genes in all normal and tumor tissues

RW Hu, C Liu, JP Gong, ZX Cao - Eur Rev Med Pharmacol Sci, 2021 - europeanreview.org
The outbreak of COVID-19 seriously affected people's life and safety, and it has not been
effectively controlled all over the world at present. The binding of S protein of SARS-COV-2 …

[PDF][PDF] Gene expression analysis identifies genes associated with SARS-COV-2 receptors, ACE2 and TMPRSS2, in normal human lung tissues

RW Hu, C Liu, JP Gong, ZX Cao - Eur Rev Med Pharmacol Sci, 2021 - europeanreview.org
The COVID-19 (Corona Virus Disease 2019) outbreak, which seriously affected people's
lives across the world, has not been effectively controlled. Previous studies have …

[HTML][HTML] In silico prediction of COVID-19 cytokine storm in lung cancer types

S Suchanti, S Awasthi, G Singh, PK Yadav… - … and Biophysics Reports, 2022 - Elsevier
Lung cancer is one of the most frequently diagnosed malignant tumors and the leading
cause of cancer-related death worldwide. Mainly, Non-small-cell lung cancer (NSCLC) …

[PDF][PDF] COVID-19: ACE-2 receptor, TMPRSS2, Cathepsin-L/B and CD-147 receptor

S Bittmann, E Moschüring-Alieva, W Anne… - J Regen Biol …, 2020 - pdfs.semanticscholar.org
COVID-19 shows an extremely rapid spreading pattern, classified as SARS-CoV-2, has
become a worldwide health problem. Relating to biological characteristics of SARS-CoV-2 …

[HTML][HTML] Analysis of 2019-nCoV receptor ACE2 expression in different tissues and its significance study

T Han, J Kang, G Li, J Ge, J Gu - Annals of Translational Medicine, 2020 - ncbi.nlm.nih.gov
Background On March 11, 2020, the World Health Organization (WHO) officially announced
that the coronavirus disease 2019 (COVID-19) had reached global pandemic status. Current …

Systematic analysis of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignant tumors: pan-cancer analysis

J Song, J Han, F Liu, X Chen, S Qian… - Frontiers in Molecular …, 2020 - frontiersin.org
Background Coronavirus disease 2019 (COVID-19) was first detected in patients with
pneumonia in December 2019 in China and it spread rapidly to the rest of the world …

Molecular pathogenesis, immunopathogenesis and novel therapeutic strategy against COVID-19

SK Chatterjee, S Saha, MNM Munoz - Frontiers in molecular …, 2020 - frontiersin.org
The coronavirus disease 2019 (COVID-19), is a highly contagious transmittable disease
caused by a recently discovered coronavirus, pathogenic SARS-CoV-2. Followed by the …

Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients

P Ren, C Gong, S Ma - Open Medicine, 2020 - degruyter.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is now a serious
public health problem. Angiotensin-converting enzyme 2 (ACE2) recognized as the receptor …

Gene expression of ACE2 gene in patients infected with COVID-19 and comparing them with vaccine recipients

MAK Mahmoud, N Khudhair - Research Journal of Pharmacy …, 2023 - indianjournals.com
COVID-19 virus caused by severe acute respiratory syndrome (SARS-Cov-2) poses a great
threat to human life and public health as it enters the body through ACE2 receptors in lung …

The landscape of coronavirus disease 2019 (COVID-19) and integrated analysis SARS-CoV-2 receptors and potential inhibitors in lung adenocarcinoma patients

B Tang, J Zhu, Y Cong, W Yang, C Kong… - Frontiers in Cell and …, 2020 - frontiersin.org
The outbreak of novel coronavirus disease 2019 (COVID-19) has become the largest health
threat worldwide, with more than 34.40 million positive cases and over 1.02 million deaths …